av/glaxosmithkline--big.svg

NYSE:GSK

GSK plc

  • Stock

USD

Last Close

1,783.50

17/05 11:14

Market Cap

628.30M

Beta: 0.28

Volume Today

1.82M

Avg: 3.25M

PE Ratio

11.06

PFCF: 21.23

Dividend Yield

4.19%

Payout:38.42%

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
3.93B
-
4.07B
3.33%
4.47B
10.04%
4.91B
9.74%
5.33B
8.57%
5.52B
3.51%
5.71B
3.53%
5.97B
4.55%
5.89B
1.37%
5.46B
7.22%
5.32B
2.61%
average payables
8.19B
-
8.14B
0.59%
8.57B
5.37%
10.58B
23.36%
16.47B
55.68%
17.50B
6.29%
14.49B
17.23%
15.39B
6.22%
16.70B
8.50%
16.91B
1.27%
16.05B
5.06%
average receivables
7.44B
-
book value per share
1.81
-
1.11
38.78%
1.32
19.39%
0.29
78.15%
-0.02
106.02%
1.11
6,475.23%
3.03
173.03%
3.66
21.01%
3.76
2.64%
2.63
30.01%
3.25
23.33%
capex per share
-0.44
-
-0.46
3.43%
-0.49
8.05%
-0.60
22.99%
-0.56
6.88%
-0.46
18.90%
-0.55
19.63%
-0.56
2.91%
-0.73
30.19%
-0.56
23.40%
-0.57
1.66%
capex to depreciation
-1.20
-
-0.86
28.10%
-1.02
18.13%
-1.26
23.79%
-0.74
41.55%
-1.02
37.91%
-0.72
29.13%
-3.59
397.00%
-1.16
67.64%
-0.98
15.38%
-0.82
16.27%
capex to operating cash flow
-0.24
-
-0.34
43.63%
-0.74
118.74%
-0.36
51.08%
-0.32
12.08%
-0.21
33.00%
-0.27
26.46%
-0.27
1.65%
-0.37
38.96%
-0.31
17.25%
-0.37
21.06%
capex to revenue
-0.06
-
-0.08
18.60%
-0.08
4.41%
-0.08
6.13%
-0.07
13.50%
-0.06
20.12%
-0.06
9.97%
-0.07
2.47%
-0.09
30.85%
-0.08
10.38%
-0.08
0.37%
cash per share
1.45
-
1.15
20.93%
1.53
33.35%
1.28
16.07%
1.00
21.98%
1.01
0.63%
1.21
20.11%
1.60
32.31%
1.08
32.32%
1.96
80.67%
1.26
35.57%
days of inventory on hand
165.81
-
210.89
27.18%
194.44
7.80%
200.46
3.10%
196.12
2.16%
195.17
0.49%
182.98
6.25%
186.99
2.19%
181.92
2.71%
196.60
8.07%
239.24
21.69%
days payables outstanding
353.61
-
396.65
12.17%
378.94
4.47%
470.06
24.05%
740.09
57.45%
500.29
32.40%
459.64
8.13%
493.98
7.47%
552.20
11.79%
621.31
12.51%
689.44
10.97%
days sales outstanding
93.37
-
debt to assets
0.43
-
0.46
6.59%
0.31
32.65%
0.32
2.20%
0.30
4.70%
0.45
48.09%
0.38
14.71%
0.34
11.82%
0.31
9.47%
0.35
14.18%
0.31
12.49%
debt to equity
2.61
-
4.41
68.98%
3.25
26.19%
16.72
414.02%
-251.31
1,603.31%
5.98
102.38%
2.55
57.41%
1.86
26.89%
1.61
13.73%
1.98
23.33%
1.35
31.83%
dividend yield
0.06
-
0.07
22.89%
0.07
0.55%
0.08
9.39%
0.08
5.34%
0.07
11.39%
0.06
16.19%
0.07
32.58%
0.06
16.47%
0.06
2.96%
0.04
37.08%
earnings yield
0.09
-
0.05
40.34%
0.16
204.80%
0.01
90.54%
0.03
97.45%
0.06
108.43%
0.07
6.75%
0.11
63.11%
0.07
36.64%
0.09
25.62%
0.08
2.78%
enterprise value
75.45B
-
67.76B
10.19%
64.26B
5.17%
75.07B
16.83%
65.30B
13.01%
81.24B
24.41%
96.72B
19.06%
74.68B
22.80%
84.68B
13.40%
75.14B
11.27%
74.70B
0.59%
enterprise value over ebitda
8.83
-
11.84
34.17%
5.22
55.90%
16.55
216.85%
9.14
44.78%
11.04
20.83%
9.55
13.51%
8.80
7.83%
9.64
9.50%
8.53
11.46%
7.94
7.00%
ev to operating cash flow
10.45
-
13.09
25.31%
25.01
91.06%
11.55
53.80%
9.44
18.30%
9.65
2.21%
12.06
25.01%
8.85
26.65%
10.65
20.38%
10.15
4.69%
11.77
15.93%
ev to sales
2.85
-
2.95
3.47%
2.69
8.81%
2.69
0.22%
2.16
19.63%
2.64
21.85%
2.87
8.71%
2.19
23.58%
2.48
13.35%
2.56
3.23%
2.46
3.88%
free cash flow per share
1.43
-
0.89
37.67%
0.17
80.59%
1.07
516.81%
1.21
13.17%
1.69
39.68%
1.48
12.18%
1.56
5.27%
1.25
19.49%
1.28
1.88%
0.97
23.79%
free cash flow yield
0.09
-
0.06
27.00%
0.01
80.55%
0.07
442.17%
0.09
33.74%
0.11
23.81%
0.08
26.39%
0.12
39.55%
0.08
32.75%
0.09
14.70%
0.07
24.45%
graham net net
-6.91
-
-7.59
9.76%
-9.39
23.77%
-11.98
27.54%
-11.82
1.34%
-12.13
2.65%
-13.54
11.57%
-12.62
6.75%
-12.62
0.00%
-9.84
22.09%
-7.90
19.72%
graham number
7.57
-
4.23
44.16%
8.05
90.55%
1.24
84.66%
0.39
68.29%
4.80
1,124.37%
8.94
86.47%
10.91
22.02%
9.63
11.76%
8.51
11.63%
9.36
9.98%
income quality
1.28
-
1.83
42.48%
0.31
83.22%
6.12
1,893.67%
3.19
47.86%
2.08
34.74%
1.52
26.85%
1.32
13.20%
1.56
18.09%
1.50
3.59%
1.29
14.37%
intangibles to total assets
0.32
-
0.30
7.55%
0.41
37.89%
0.42
2.51%
0.41
1.33%
0.40
4.17%
0.52
31.58%
0.50
3.53%
0.51
2.21%
0.36
30.85%
0.12
67.50%
interest coverage
9.16
-
4.95
46.00%
13.64
175.59%
3.53
74.11%
5.57
57.74%
6.87
23.40%
7.63
11.09%
8.73
14.32%
7.91
9.35%
7.32
7.47%
8.29
13.23%
interest debt per share
4.92
-
5.07
3.12%
4.50
11.30%
5.02
11.62%
4.56
9.21%
6.83
49.86%
7.94
16.19%
7.04
11.28%
6.23
11.49%
5.43
12.89%
4.58
15.75%
inventory turnover
2.20
-
1.73
21.37%
1.88
8.46%
1.82
3.00%
1.86
2.21%
1.87
0.49%
1.99
6.66%
1.95
2.15%
2.01
2.79%
1.86
7.47%
1.53
17.83%
invested capital
2.61
-
4.41
68.98%
3.25
26.19%
16.72
414.02%
-251.31
1,603.31%
5.98
102.38%
2.55
57.41%
1.86
26.89%
1.61
13.73%
1.98
23.33%
1.35
31.83%
market cap
62.74B
-
53.32B
15.02%
53.45B
0.26%
61.18B
14.45%
52.05B
14.92%
59.05B
13.46%
70.92B
20.10%
53.82B
24.12%
64.79B
20.38%
57.88B
10.66%
59.62B
3.01%
net current asset value
-19.05B
-
-21.04B
10.45%
-27.98B
33.01%
-37.41B
33.69%
-36.98B
1.13%
-37.47B
1.30%
-41.84B
11.68%
-39.38B
5.90%
-39.09B
0.73%
-29.28B
25.09%
-27.57B
5.86%
net debt to ebitda
1.49
-
2.53
69.79%
0.88
65.23%
3.06
248.81%
1.86
39.43%
3.02
62.57%
2.55
15.54%
2.46
3.48%
2.26
7.88%
1.96
13.43%
1.60
18.27%
net income per share
1.41
-
0.72
49.06%
2.18
204.13%
0.23
89.24%
0.39
67.09%
0.92
135.14%
1.17
27.35%
1.44
23.04%
1.10
24.15%
1.22
11.58%
1.20
1.93%
operating cash flow per share
1.87
-
1.35
27.99%
0.66
50.60%
1.67
151.39%
1.77
5.91%
2.14
21.03%
2.03
5.40%
2.12
4.63%
1.99
6.31%
1.84
7.44%
1.54
16.02%
payables turnover
1.03
-
0.92
10.85%
0.96
4.67%
0.78
19.39%
0.49
36.49%
0.73
47.93%
0.79
8.84%
0.74
6.95%
0.66
10.54%
0.59
11.12%
0.53
9.88%
receivables turnover
3.91
-
research and ddevelopement to revenue
0.15
-
0.15
1.32%
0.15
0.77%
0.13
12.58%
0.15
13.99%
0.13
14.82%
0.14
7.14%
0.15
10.47%
0.15
3.49%
0.19
20.96%
0.21
9.60%
return on tangible assets
0.19
-
0.10
49.32%
0.27
176.54%
0.03
90.03%
0.05
74.35%
0.10
123.07%
0.12
17.80%
0.14
18.09%
0.11
20.68%
0.13
11.33%
0.09
25.59%
revenue per share
6.86
-
5.98
12.79%
6.19
3.49%
7.17
15.88%
7.72
7.66%
7.84
1.52%
8.53
8.79%
8.57
0.43%
8.52
0.51%
7.28
14.53%
7.38
1.29%
roe
0.78
-
0.65
16.79%
1.65
154.74%
0.81
50.73%
-22.53
2,876.65%
0.83
103.69%
0.39
53.36%
0.39
1.68%
0.29
26.10%
0.46
59.42%
0.37
20.48%
roic
0.23
-
0.15
36.88%
0.38
153.72%
0.07
81.07%
0.15
106.64%
0.15
2.99%
0.13
11.09%
0.17
23.55%
0.14
13.34%
0.17
19.60%
0.18
6.14%
sales general and administrative to revenue
0.32
-
0.36
12.03%
0.39
7.67%
0.34
12.98%
0.32
4.59%
0.32
0.40%
0.34
5.00%
0.34
0.54%
0.32
4.24%
0.29
11.26%
shareholders equity per share
1.81
-
1.11
38.78%
1.32
19.39%
0.29
78.15%
-0.02
106.02%
1.11
6,475.23%
3.03
173.03%
3.66
21.01%
3.76
2.64%
2.63
30.01%
3.25
23.33%
stock based compensation to revenue
0.01
-
0.01
19.90%
0.02
6.59%
0.01
25.64%
0.01
3.55%
0.01
5.88%
0.01
7.42%
0.01
3.33%
0.01
3.72%
0.01
9.68%
tangible asset value
-5.68B
-
-7.11B
25.23%
-12.96B
82.27%
-19.78B
52.66%
-19.81B
0.15%
-19.32B
2.46%
-23.16B
19.88%
-19.61B
15.32%
-19.29B
1.65%
-11.27B
41.58%
5.98B
153.11%
tangible book value per share
-1.47
-
-1.85
25.83%
-3.35
81.41%
-5.09
51.74%
-5.07
0.39%
-4.91
3.02%
-5.85
19.08%
-4.93
15.81%
-4.82
2.19%
-2.80
41.92%
1.46
152.01%
working capital
1.55B
-
1.38B
10.77%
3.17B
129.21%
-2.29B
172.24%
-10.66B
365.59%
-5.56B
47.81%
-4.56B
18.06%
-1.90B
58.30%
-5.00B
162.81%
-2.04B
59.15%
-2.42B
18.77%

All numbers in USD (except ratios and percentages)